CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
HEPHAISTOS-Pharma
start up
France
- Orsay, Île-de-France
- 17/05/2024
- Seed
- $11,189,199
HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.
- Industry Biotechnology
- Website https://hephaistos-pharma.fr/
- LinkedIn https://www.linkedin.com/company/hephaistos-pharma/
Related People
Frederic CAROFFFounder
France -
Boulogne-Billancourt, Île-de-France
Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.
Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)